No Drip Severe Nasal Mist by Sheffield Pharmaceuticals LLC / Sheffield Pharmaceutical LLC

No Drip Severe Nasal Mist by

Drug Labeling and Warnings

No Drip Severe Nasal Mist by is a Otc medication manufactured, distributed, or labeled by Sheffield Pharmaceuticals LLC, Sheffield Pharmaceutical LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

NO DRIP SEVERE NASAL MIST- oxymetazoline spray liquid 
Sheffield Pharmaceuticals LLC

----------

Drug Facts

Active Ingredient
Oxymetazoline Hydrochloride 0.05%

Purpose

Nasal Decongestant

Uses

Temporarily relieves nasal congestion due to:

  • common cold
  • hay fever
  • upper respiroty allergies
  • temporarily relieves sinus congestion and pressure
  • Shrinks swollen membranes so you can breathe more freely

Warnings

Ask a Doctor before use if you have

  • heart diease
  • high blood pressure
  • diabetes
  • thyiod diease
  • trouble urinating due to enlarged rostate gland.

When using this product

  • Do not use more than directed
  • do not use for more than three days, Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
  • temporary discomfort such as burning ,stinging, sneezing or an increase in nasal discharge may occur.
  • use of this container by more than one person may spread infection.

stop use and ask a doctor if

symptoms persist.

if pregnant or breast-feeding 

ask a health professional before use.

Keep out of the reach of children

if swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Before using for the first time, remove the protective cap form the tip and prime the pump by depressing pump firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostrile. Fully depress rim with a firm and even stroke, and sniff deeply.
  • Wipe nozzle clean after use.
  • Adults and children 6 to under 12 years of age (with adult supervision):2 or 3 sprays in each nostril not more than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
  • Children under 6 years of age consult a doctor.

Other information

  • store between 20° and 25°C (68° to 77°F)
  • retain carton for future reference on full labeling

Inactive Ingredients

Benzalkonium Chloride, Camphor, Cellulose Gum, Disodium EDTA, Disodium Phosphate, Eucalyptol, Glycerin, Menthol, Microcrystalline Cellulose and Carboxymethylcellulose Sodium, PEG-6, Povidone, Propylene Glycol, Sodium Phosphate, Water (purified)

Principal Panel 0.5 FLOZ Bottle

Principal Panel 0.5 FLOZ Bottle

Sheffield         NDC: 11527-145-55

No Drip Severe Nasal Mist 

Nasal Spray 

Oxymetazoline HCL 0.05%

12 hour Nasal Spray

Net Wt 30 ml (1.01 FLOZ)

Principal Panel 0.5 FLOZ Bottle

Principal Panel 0.5 FLOZ Bottle

Principal display panel- Carton label

Sheffield  No Drip Severe Nasal Mist    NDC: 11527-145-55

Nasal Spray

Oxymetazoline HCL 0.05%

12 hour Nasal Spray

Net Wt  30ml (1.01FLOZ)

Principal display panel- Carton label

Principal display panel- Carton label
NO DRIP SEVERE NASAL MIST 
oxymetazoline spray liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 11527-145
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OXYMETAZOLINE HYDROCHLORIDE (UNII: K89MJ0S5VY) (OXYMETAZOLINE - UNII:8VLN5B44ZY) OXYMETAZOLINE HYDROCHLORIDE50 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
GLYCERIN (UNII: PDC6A3C0OX)  
POLYETHYLENE GLYCOL 300 (UNII: 5655G9Y8AQ)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
SODIUM PHOSPHATE, MONOBASIC (UNII: 3980JIH2SW)  
SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
WATER (UNII: 059QF0KO0R)  
POVIDONE (UNII: FZ989GH94E)  
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)  
CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)  
MENTHOL (UNII: L7T10EIP3A)  
EUCALYPTOL (UNII: RV6J6604TK)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 11527-145-551 in 1 CARTON12/22/202012/30/2020
130 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01212/22/202012/30/2020
Labeler - Sheffield Pharmaceuticals LLC (151177797)
Registrant - Sheffield Pharmaceuticals LLC (151177797)
Establishment
NameAddressID/FEIBusiness Operations
Sheffield Pharmaceutical LLC151177797manufacture(11527-145)

Revised: 2/2025